Arber, D. A., Carter, N. H., Ikle, D., Slovak, M. L. "Value of combined morphologic, cytochemical, and immunophenotypic features in predicting recurrent cytogenetic abnormalities in acute myeloid leukemia. "Hum Pathol; 2003, 34(5): 479-83
Arber, D. A., Chang, K. L., Lyda, M. H., Bedell, V., Spielberger, R., Slovak, M. L. "Detection of NPM/MLF1 fusion in t(3;5)-positive acute myeloid leukemia and myelodysplasia. "Human Pathology; 2003, 34(8): 809-813
Arber, D. A., Stein, A. S., Carter, N. H., Ikle, D., Forman, S. J., Slovak, M. L. "Prognostic impact of acute myeloid leukemia classification. Importance of detection of recurring cytogenetic abnormalities and multilineage dysplasia on survival. "Am J Clin Pathol; 2003, 119(5): 672-80
Battiwalla, M., Melenhorst, J., Saunthararajah, Y., Nakamura, R., Molldrem, J., Young, N. S., Barrett, A. J. "HLA-DR4 predicts haematological response to cyclosporine in T-large granular lymphocyte lymphoproliferative disorders. "British Journal of Haematology; 2003, 123(3): 449-453
Bhatia, R., Holtz, M., Niu, N., Gray, R., Snyder, D. S., Sawyers, C. L., Arber, D. A., Slovak, M. L., Forman, S. J. "Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment. "Blood; 2003, 101(12): 4701-7
Chang, K. L., Gaal, K. K., Huang, Q., Weiss, L. M. "Histiocytic lesions involving the bone marrow. "Seminars in Diagnostic Pathology; 2003, 20(3): 226-236
Chiu, K. C., Fine, M., Ikle, D., Slovak, M. L., Arber, D. A. "Telomerase activity and proliferation index in aggressive mature B-cell lymphoma: Comparison to germinal center phenotypic markers. "Human Pathology; 2003, 34(12): 1259-1264
Chu, P. G., Arber, D. A., Weiss, L. M. "Expression of T/NK-cell and plasma cell antigens in nonhematopoietic epithelioid neoplasms. An immunohistochemical study of 447 cases. "Am J Clin Pathol; 2003, 120(1): 64-70
Chu, P. G., Jiang, Z., Weiss, L. M. "Hepatocyte antigen as a marker of intestinal metaplasia. "Am J Surg Pathol; 2003, 27(7): 952-9
Chu, P. G., Weiss, L. M., Benhattar, J., Meagher-Villemure, K. "Intraneural synovial sarcoma. "Mod Pathol; 2003; 17: 258-263
Cooper, L. J. N., Topp, M. S., Serrano, L. M., Gonzalez, S., Chang, W. C., Naranjo, A., Wright, C., Popplewell, L., Raubitschek, A., Forman, S. J., Jensen, M. C. "T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B-lineage leukemia effect. "Blood; 2003, 101(4): 1637-1644
Daftarian, P., Ali, S., Sharan, R., Lacey, S. F., La Rosa, C., Longmate, J., Buck, C., Siliciano, R. F., Diamond, D. J. "Immunization with Th-CTL fusion peptide and cytosine-phosphate-guanine DNA in transgenic HLA-A2 mice induces recognition of HIV-infected T cells and clears vaccinia virus challenge. "Journal of Immunology; 2003, 171(8): 4028-4039
Douer, D., Santillana, S., Ramezani, L., Samanez, C., Slovak, M. L., Lee, M. S., Watkins, K., Williams, T., Vallejos, C. "Acute promyelocytic leukaemia in patients originating in Latin America is associated with an increased frequency of the bcr1 subtype of the PML/RAR alpha fusion gene. "British Journal of Haematology; 2003, 122(4): 563-570
Espenschied, J., Lamont, J., Longmate, J., Pendas, S., Wang, Z., Diamond, D. J., Ellenhorn, J. D. "CTLA-4 blockade enhances the therapeutic effect of an attenuated poxvirus vaccine targeting p53 in an established murine tumor model. "J Immunol; 2003, 170(6): 3401-7.
Feinstein, L. C., Sandmaier, B. M., Maloney, D. G., Maris, M. B., Gooley, T. A., Chauncey, T. R., Hegenbart, U., McSweeney, P. A., Stuart, M. J., Forman, S. J., Agura, E. A., Pulsipher, M. A., Blume, K. G., Niederwieser, D. W., Storb, R. F. "Allografting after nonmyeloablative conditioning as a treatment after a failed conventional hematopoietic cell transplant. "Biol Blood Marrow Transplant; 2003, 9(4): 266-72
Figarola, J. L., Scott, S., Loera, S., Tessler, C., Chu, P., Weiss, L., Hardy, J., Rahbar, S. "LR-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats. "Diabetologia; 2003, 46(8): 1140-1152
Fung, H. C., Cohen, S., Rodriguez, R., Smith, D., Krishnan, A., Somlo, G., Sahebi, F., Senitzer, D., O'Donnell, M. R., Stein, A., Snyder, D. S., Spielberger, R., Bhatia, R., Falk, P., Molina, A., Nademanee, A., Parker, P., Kogut, N., Popplewell, L., Vora, N., Margolin, K., Forman, S. J. "Reduced-intensity allogeneic stem cell transplantation for patients whose prior autologous stem cell transplantation for hematologic malignancy failed. "Biology of Blood and Marrow Transplantation; 2003, 9(10): 649-656
Fung, H. C., Stein, F., Slovak, M. L., O'Donnell, M. R., Snyder, D. S., Cohen, S., Smith, D., Krishnan, A., Spielberger, R., Bhatia, R., Bhatia, S., Falk, P., Molina, A., Nademanee, A., Parker, P., Rodriguez, R., Rosenthal, J., Sweetman, R., Kogut, N., Sahebi, F., Popplewell, L., Vora, N., Somlo, G., Margolin, K., Chow, W., Smith, E., Forman, S. J. "A long-term follow-up report on allogeneic stem cell transplantation for patients with primary refractory acute myelogenous leukemia: Impact of cytogenetic characteristics on transplantation outcome. "Biology of Blood and Marrow Transplantation; 2003, 9(12): 766-771
Gallez-Hawkins, G., Villacres, M. C., Li, X., Sanborn, M. C., Lomeli, N. A., Zaia, J. A. "Use of transgenic HLA A*0201/Kb and HHD II mice to evaluate frequency of cytomegalovirus IE1-derived peptide usage in eliciting human CD8 cytokine response. "J Virol; 2003, 77(7): 4457-62
Hegenbart, U., Niederwieser, D., Forman, S., Holler, E., Leiblein, S., Johnston, L., Ponisch, W., Epner, E., Witherspoon, R., Blume, K., Storb, R. "Hematopoietic cell transplantation from related and unrelated donors after minimal conditioning as a curative treatment modality for severe paroxysmal nocturnal hemoglobinuria. "Biology of Blood and Marrow Transplantation; 2003, 9(11): 689-697
Huhn, R. D., Fogarty, P. F., Nakamura, R., Read, E. J., Leitman, S. F., Rick, M. E., Kimball, J., Greene, A., Hansmann, K., Gratwohl, A., Young, N., Barrett, A. J., Dunbar, C. E. "High-dose cyclophosphamide with autologous lymphocyte-depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopenia. "Blood; 2003, 101(1): 71-7.
Ishizawa, S., Slovak, M. L., Popplewell, L., Bedell, V., Wrede, J. E., Carter, N. H., Snyder, D. S., Arber, D. A. "High frequency of pro-B acute lymphoblastic leukemia in adults with secondary leukemia with 11q23 abnormalities. "Leukemia; 2003, 17(6): 1091-5
Jensen, M. C., Cooper, L. J. N., Wu, A. M., Forman, S. J., Raubitschek, A.A. "Immunobiology of engineered CD20-specific primary human cytotoxic T lymphocytes for targeting B-cell malignancy. "Cytotherapy; 2003; 5: 131-138
Lacey, S. F., Villacres, M. C., La Rosa, C., Wang, Z. D., Longmate, J., Martinez, J., Brewer, J. C., Mekhoubad, S., Maas, R., Leedom, J. M., Forman, S. J., Zaia, J. A., Diamond, D. J. "Relative dominance of HLA-B*07 restricted CD8(+) T-lymphocyte immune responses to human cytomegalovirus pp65 in persons sharing HLA-A*02 and HLA-B*07 alleles. "Human Immunology; 2003, 64(4): 440-452
Li, M. J., Bauer, G., Michienzi, A., Yee, J. K., Lee, N. S., Kim, J., Li, S., Castanotto, D., Zaia, J., Rossi, J. J. "Inhibition of HIV-1 infection by lentiviral vectors expressing pol III-promoted anti-HIV RNAs. "Molecular Therapy; 2003, 8(2): 196-206
Li, M. J., McMahon, R., Snyder, D. S., Yee, J. K., Rossi, J. J. "Specific killing of Ph+ chronic myeloid leukemia cells by a lentiviral vector-delivered anti-bcr/abl small hairpin RNA. "Oligonucleotides; 2003, 13(5): 401-409
Maloney, D. G., Molina, A. J., Sahebi, F., Stockerl-Goldstein, K. E., Sandmaier, B. M., Bensinger, W., Storer, B., Hegenbart, U., Somlo, G., Chauncey, T., Bruno, B., Appelbaum, F. R., Blume, K. G., Forman, S. J., McSweeney, P., Storb, R. "Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma. "Blood; 2003, 102(9): 3447-3454
Michel, G., Rocha, V., Chevret, S., Arcese, W., Chan, K. W., Filipovich, A., Takahashi, T. A., Vowels, M., Ortega, J., Bordigoni, P., Shaw, P. J., Yaniv, I., Machado, A., Pimentel, P., Fagioli, F., Verdeguer, A., Jouet, J. P., Diez, B., Ferreira, E., Pasquini, R., Rosenthal, J., Sievers, E., Messina, C., Iori, A. P., Garnier, F., Ionescu, I., Locatelli, F., Gluckman, E. "Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis. "Blood; 2003, 102(13): 4290-4297
Qiu, W., David, D., Zhou, B., Chu, P. G., Zhang, B., Wu, M., Xiao, J., Han, T., Zhu, Z., Wang, T., Liu, X., Lopez, R., Frankel, P., Jong, A., Yen, Y. "Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma. "Am J Pathol; 2003, 162(6): 1961-74
Stein, A. S., Nademanee, A., O'Donnell, M. R., Lee, J., Schmidt, G. M., Parker, P. M., Snyder, D. S., Smith, E. P., Somlo, G., Margolin, K. A., Fahey, J., Niland, J. C., Forman, S. J. "High dose cytosine arabinoside and daunorubicin induction therapy for acute myelogenous leukemia - results for 100 consecutive treated patients and analysis of adverse prognostic factors impact on achieving a remission. "Leukemia; 2003; 14: 1191-6
Stein, A. S., O'Donnell, M. R., Slovak, M. L., Snyder, D. S., Nademanee, A. P., Parker, P., Molina, A., Somlo, G., Fung, H. C., Krishnan, A., Rodriguez, R., Spielberger, R. T., Wang, S., Dagis, A., Vora, N., Arber, D. A., Niland, J. C., Forman, S. J. "Interleukin-2 after autologous stem-cell transplantation for adult patients with acute myeloid leukemia in first complete remission. "J Clin Oncol; 2003, 21(4): 615-23
Stiff, P. J., Unger, J. M., Forman, S. J., McCall, A. R., LeBlanc, M., Nademanee, A. P., Bolwell, B. J., Fisher, R. I. "The value of augmented preparative regimens combined with an autologous bone marrow transplant for the management of relapsed or refractory Hodgkin disease: A Southwest Oncology Group Phase II Trial. "Biology of Blood and Marrow Transplantation; 2003, 9(8): 529-539
Sun, J. Y., Anand-Jawa, V., Chatterjee, S., Wong, K. K. "Immune responses to adeno-associated virus and its recombinant vectors. "Gene Ther; 2003, 10(11): 964-76
Sun, J. Y., Senitzer, D., Forman, S. J., Chatterjee, S., Wong, K. K. "Identification of new MHC-restriction elements for presentation of the p210(BCR-ABL) fusion region to human cytotoxic T lymphocytes. "Cancer Immunology Immunotherapy; 2003, 52(12): 761-770
Villacres, M. C., Lacey, S. F., Auge, C., Longmate, J., Leedom, J. M., Diamond, D. J. "Relevance of peptide avidity to the T cell receptor for cytomegalovirus-specific ex vivo CD8 T cell cytotoxicity. "Journal of Infectious Diseases; 2003, 188(6): 908-918
Zeng, D. F., Liu, Y. P., Sidobre, S., Kronenberg, M., Strober, S. "Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupus. "Journal of Clinical Investigation; 2003, 112(8): 1211-1222
Saunthararajah, Y., Nakamura, R., Wesley, R., Wang, Q. J., Barrett, A. J. "A simple method to predict response to immunosuppressive therapy in patients with myelodysplastic syndrome. "Blood; 2003, 102(8): 3025-7
Solomon, S. R., Nakamura, R., Read, E. J., Leitman, S. F., Carter, C., Childs, R., Dunbar, C. E., Young, N. S., Barrett, A. J. "Cyclosporine is required to prevent severe acute GVHD following T-cell-depleted peripheral blood stem cell transplantation. "Bone Marrow Transplantation; 2003, 31(9): 783-8
Fujiwara, H., Sconocchia, G., Melenhorst, J., Eniafe, R., Nakamura, R., Hensel, N., Barrett, A. J. "Tissue-restricted T cell alloresponses across HLA barriers: selection and identification of leukemia-restricted CTL in HLA-mismatched stimulator-responder pairs. "Bone Marrow Transplantation; 2003, 32(4): 371-8
Lan, F., Zeng, D., Higuchi, M., Higgins, J. P., Strober, S. "Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer T cells. "Biology of Blood & Marrow Transplantation; 2003, 9(6): 355-63
Michienzi, A., Castanotto, D., Lee, N., Li, S., Zaia, J. A., Rossi, J. J. "RNA-mediated inhibition of HIV in a gene therapy setting. "Therapeutic Oligonucleotides; 2003; 1002: 63-71
